Sunday, September 20, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $336.13 -0.26%
MSFT $493.78 -0.80%
GOOGL $349.54 +0.64%
AMZN $253.71 +1.00%
TSLA $364.27 -0.53%
META $665.75 -2.43%
NVDA $222.27 +1.34%
JPM $349.67 +0.10%
BTC $35.91 +6.18%
ETH $25.18 +7.79%
AAPL
$336.13
▼ 0.26%
MSFT
$493.78
▼ 0.80%
GOOGL
$349.54
▲ 0.64%
AMZN
$253.71
▲ 1.00%
TSLA
$364.27
▼ 0.53%
META
$665.75
▼ 2.43%
NVDA
$222.27
▲ 1.34%
JPM
$349.67
▲ 0.10%
Bloomberg Markets
Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Eli Lilly plans to buy Merida Biosciences Inc. for as much as $2.88 billion in cash to expand in autoimmune and allergic diseases, part of an effort to build beyond the weight-loss and diabetes markets that made it the largest pharmaceutical company in the world. (Source: Bloomberg)
business  Sep 2, 2026
Bloomberg Markets
A surge of mergers and public offerings in the final months of 2026 could push dealmaking volumes to a new high, despite growing concerns over the economy, according to Dorothee Blessing, co-head of global investment banking at JPMorgan Chase & Co.
business  Sep 2, 2026
Bloomberg Markets
Bloomberg's Liana Baker joins Dani Burger on "Bloomberg Deals."  S&P Global is considering spinning out its flagship data and research platform Capital IQ Pro, in a move that could create a standalone firm worth billions of dollars. (Source: Bloomberg)
business  Sep 2, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free